Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.12 | - | - |
| Carbylan Therapeutics Inc | 0 | 1 | 0 | 0 | €10.50 | - | - |
| Innate Pharma | 0 | 1 | 0 | 0 | €1.97 | - | - |
| Uniqure B.V. | 1 | 2 | 0 | 0 | €4.51 | €11.00 | 144.065% |
| Bayer AG ADR | 0 | 1 | 0 | 0 | €7.65 | - | - |
| Adocia | 0 | 1 | 0 | 1 | €5.55 | - | - |
| Palatin Technologies Inc. | 0 | 1 | 0 | 0 | €0.79 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 0 | 1 | 0 | 0 | €2.65 | - | - |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.60 | €50.00 | 36.612% |
| Aspira Womens Health Inc. | 1 | 1 | 0 | 0 | €0.73 | €4.99 | 588.607% |
| Medigene AG | 1 | 1 | 0 | 0 | €1.06 | - | - |
| Inventiva SA | 1 | 1 | 0 | 1 | €1.63 | €6.00 | 267.197% |
| Protalix Biotherapeutics Inc. | 1 | 1 | 0 | 0 | €0.91 | €2.00 | 119.346% |
| Corbus Pharmaceuticals Holding Inc. | 1 | 1 | 0 | 0 | €17.80 | €50.00 | 180.899% |
| Fate Therapeutics Inc. | 3 | 3 | 0 | 0 | €2.90 | €7.31 | 151.996% |
| Cytomx Therapeutics Inc | 2 | 1 | 0 | 0 | €1.04 | €50.00 | 4698.464% |
| Compugen Ltd. | 3 | 2 | 0 | 0 | €1.65 | €3.66 | 122.637% |
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.55 | - | - |
| Bluebird Bio Inc. | 7 | 6 | 0 | 0 | €0.51 | €5.47 | 973.412% |
| Cara Therapeutics Inc. | 10 | 8 | 0 | 1 | €0.21 | €4.61 | 2089.184% |
| Agenus Inc. | 4 | 2 | 0 | 0 | €0.41 | €37.02 | 8846.834% |
| Rocket Pharmaceuticals Inc | 3 | 1 | 1 | 0 | ? | €26.50 | 77.852% |
| Inotiv Inc. | 4 | 1 | 1 | 0 | €1.71 | €9.93 | 480.602% |
| Sage Therapeutics Inc. | 5 | 2 | 0 | 0 | €6.31 | €23.82 | 277.405% |
| Ironwood Pharmaceuticals | 9 | 1 | 0 | 0 | €3.74 | €18.27 | 388.503% |